GlobeNewswire
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
📈
AI Sentiment
Highly Positive
8/10
Cocrystal Pharma Inc. News
Latest updates and market news for COCP
1 news
Dec 16 - Dec 22, 2025
Page 1
Share this news page